DWM
KRYS icon

Dogwood Wealth Management’s Krystal Biotech KRYS Stock Holding History

Dogwood Wealth Management’s Portfolio KRYS Stock Details KRYS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.6K Buy
+7
New +$2.09K ﹤0.01% 623

Other funds holding KRYS

Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
TAM
Tealwood Asset Management Minneapolis, Minnesota $261M AUM 52.68% 1-Year Est. Return
YCM
Yousif Capital Management Bloomfield Hills, Michigan $8.94B AUM 42.6% 1-Year Est. Return
TFA
Toth Financial Advisory Leesburg, Virginia $1.02B AUM 28.36% 1-Year Est. Return
EA
Ellsworth Advisors Hudson, Ohio $609M AUM 52.37% 1-Year Est. Return
CPIA
Cornell Pochily Investment Advisors Ithaca, New York $372M AUM 29.32% 1-Year Est. Return
CGH
Crossmark Global Holdings Houston, Texas $7.71B AUM 37.66% 1-Year Est. Return
QCM
QRG Capital Management Chicago, Illinois $12.1B AUM 44.98% 1-Year Est. Return
NWAG
Net Worth Advisory Group Sandy, Utah $397M AUM 29.92% 1-Year Est. Return

Dogwood Wealth Management's KRYS Position: Q2 2026 in Review

Dogwood Wealth Management opened a new position in Krystal Biotech (KRYS) in Q2 2026: 7 shares worth $2.6K. The stake represents ﹤0.01% of the portfolio and ranks #623 among its holdings.

31 funds tracked by Wall St. Rank hold KRYS as of Q2 2026.

  • Dogwood Wealth Management held 7 shares of Krystal Biotech worth $2.6K as of Q2 2026.
  • Krystal Biotech was a new Dogwood Wealth Management position in Q2 2026.
  • Krystal Biotech made up ﹤0.01% of Dogwood Wealth Management's portfolio in Q2 2026, its #623 holding.
  • 31 funds tracked by Wall St. Rank held Krystal Biotech as of Q2 2026.

Based on Dogwood Wealth Management's 13F filing for Q2 2026, filed 6 Jul 2026.